Skip to main content

Surrozen, Inc.

SRZN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001824893

In the last 90 days, Surrozen, Inc. insiders filed 0 open-market purchases and 1 sale; 70 institutions reported holding it in 13F filings for Q2 2026, worth $324.5M in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Surrozen, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
1 filing
1 insider, $6.91M in total
Insiders trading
1
Net value
−$6.91M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Surrozen, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Surrozen, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Yu Chen-Ming10% Owner574,047IndirectJul 24, 20261
TCG Crossover GP II, LLC10% Owner574,047IndirectJul 24, 20265
TCG Crossover Fund II, L.P.10% Owner574,047IndirectJul 24, 20265
TCG Crossover Fund III, L.P.10% Owner574,047IndirectJul 24, 20265
TCG Crossover GP III, LLC10% Owner574,047IndirectJul 24, 20265
Williams Charles OChief Operating Officer18,237Jun 16, 20266
Parker Craig CChief Executive Officer18,175Jun 16, 20264
Li YangExec. Vice President, Research18,882Jun 16, 20266
Maleki Andrew PedrumChief Financial Officer607Jun 16, 20262
Kutzkey TimDirector, 10% Owner1,016,658IndirectMay 19, 20266
Bjerkholt EricDirector–May 14, 20261
Chai Christopher YDirector–May 14, 20261
Woodhouse David JDirector–May 14, 20261
Berkenblit AnnaDirector–May 14, 20261
Haak-Frendscho MaryDirector–May 14, 20261
Rothenberg MaceDirector–May 14, 20261
Svennilson Peter10% Owner1,016,658IndirectJan 20, 20263
Column Group III-A, LP10% Owner1,016,658IndirectJan 20, 20265
Column Group III, LP10% Owner1,016,658IndirectJan 20, 20265
Column Group III GP, LP10% Owner1,016,658IndirectJan 20, 20265
Column Group Opportunity III, LP10% Owner1,016,658IndirectJan 20, 20265
TCG Opportunity III GP, LLC10% Owner1,016,658IndirectJan 20, 20265
Column Group Opportunity III GP, LP10% Owner1,016,658IndirectJan 20, 20265
Lin Shao-LeeDirector–May 15, 20250
Yeh Wen-ChenChief Scientific Officer27,216Jun 20, 20230
Vanhove GeertruiChief Medical Officer32,412Dec 19, 20220
Blutt Mitchell J MD10% Owner0IndirectDec 15, 20220
Consonance Capital Management LP10% Owner0IndirectDec 15, 20220
Consonance Capman GP, LLC10% Owner0IndirectDec 15, 20220
Consonance Life Sciences10% Owner0IndirectDec 15, 20220
Livingston Kevin Harold10% Owner0IndirectDec 15, 20220
Soffer Benny10% Owner0IndirectDec 15, 20220
Santel Donald JOther: Former Director30,000Aug 13, 20210
Soffer GadOther: FORMER CHIEF EXECUTIVE OFFICER–Aug 13, 20210
Haqq ChristopherOther: Former Director30,000Aug 13, 20210
Jarrett JenniferOther: Former Director30,000Aug 13, 20210
House Joshua CoryOther: Former VP Business Development–Aug 13, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jul 24, 2026 (view filing)9:00 PM ETJul 222 daysYu Chen-Ming and 4 others10% OwnerSSale−325.0K$21.25−$6.91M−36.1%574.0K after2 lots
May 5, 2026 (view filing)May 41 dayLi YangExec. Vice President, ResearchSSale−1.58K$33.33−$52.8K−8.4%17.2K after
May 5, 2026 (view filing)May 41 dayWilliams Charles OChief Operating OfficerSSale−2.04K$33.33−$67.9K−10.9%16.6K after
May 5, 2026 (view filing)May 41 dayParker Craig CChief Executive OfficerSSale−4.52K$33.33−$150.8K−21.5%16.6K after
Mar 25, 2026 (view filing)8:02 PM ETMar 23-242 daysTCG Crossover GP II, LLC and 3 others10% OwnerPPurchase+121.9K$24.72+$3.01M+19.8%736.5K after4 lots
Mar 16, 2026 (view filing)7:05 PM ETMar 12-164 daysTCG Crossover GP II, LLC and 3 others10% OwnerPPurchase+49.0K$24.91+$1.22M+7.8%675.6K after6 lots
Feb 13, 2026 (view filing)4:19 PM ETFeb 11-122 daysTCG Crossover GP II, LLC and 3 others10% OwnerPPurchase+18.9K$23.59+$444.8K+3.0%651.1K after4 lots
Feb 3, 2026 (view filing)8:03 PM ETJan 30-Feb 34 daysTCG Crossover GP II, LLC and 3 others10% OwnerPPurchase+9.36K$21.65+$202.5K+1.5%641.7K after6 lots
Jan 20, 2026 (view filing)7:35 PM ETJan 15-205 daysSvennilson Peter and 6 others10% OwnerPPurchase+32.5K$19.74+$641.6K+3.3%1.02M after6 lots
Jan 20, 2026 (view filing)Jan 15-205 daysKutzkey TimDirector, 10% OwnerPPurchase+32.5K$19.74+$641.6K+3.3%1.02M after6 lots
Jan 15, 2026 (view filing)4:10 PM ETJan 13-142 daysSvennilson Peter and 6 others10% OwnerPPurchase+18.0K$19.86+$357.4K+1.8%999.4K after4 lots
Jan 15, 2026 (view filing)Jan 13-142 daysKutzkey TimDirector, 10% OwnerPPurchase+18.0K$19.86+$357.3K+1.8%999.4K after4 lots
Jan 8, 2026 (view filing)5:23 PM ETJan 62 daysSvennilson Peter and 6 others10% OwnerPPurchase+15.1K$19.89+$300.3K+1.5%989.9K after2 lots
Jan 8, 2026 (view filing)Jan 62 daysKutzkey TimDirector, 10% OwnerPPurchase+15.1K$19.89+$300.3K+1.5%989.9K after2 lots
Jan 6, 2026 (view filing)Jan 51 dayLi YangExec. Vice President, ResearchSSale−1.12K$19.87−$22.2K−6.5%16.1K after
Jan 6, 2026 (view filing)Jan 51 dayWilliams Charles OChief Operating OfficerSSale−1.57K$19.87−$31.1K−10.8%13.0K after
Dec 8, 2025 (view filing)5:04 PM ETDec 4-54 daysColumn Group III-A, LP and 5 others10% OwnerPPurchase+36.1K$19.22+$694.9K+3.8%981.9K after4 lots
Dec 8, 2025 (view filing)Dec 4-54 daysKutzkey TimDirector, 10% OwnerPPurchase+36.1K$19.22+$694.8K+3.8%981.9K after4 lots
Dec 2, 2025 (view filing)Nov 1319 daysLateKutzkey TimDirector, 10% OwnerPPurchase+315.5K$12.65+$3.99M+48.7%962.7K after2 lotsDuplicate filing
Nov 17, 2025 (view filing)7:15 PM ETNov 134 daysColumn Group III-A, LP and 5 others10% OwnerPPurchase+315.5K$12.65+$3.99M+48.7%962.7K after2 lots
Mar 28, 2025 (view filing)8:57 PM ETMar 262 daysColumn Group III-A, LP and 5 others10% OwnerPPurchase+1.03M$11.60+$12.0MNew position344.8K after3 lots
Mar 28, 2025 (view filing)8:57 PM ETMar 262 daysColumn Group III-A, LP and 5 others10% OwnerPPurchase+3.25M–––517.2K afterDerivative10 lots
Jan 6, 2025 (view filing)Jan 33 daysLi YangExec. Vice President, ResearchSSale−843$17.37−$14.6K−5.9%13.3K after
Jan 6, 2025 (view filing)Jan 33 daysWilliams Charles OCFO and COOSSale−1.18K$17.37−$20.5K−11.6%8.98K after
Apr 17, 2024 (view filing)4:14 PM ETApr 413 daysColumn Group III-A, LP and 2 others10% OwnerPPurchase+193.5K$15.50+$3.00M+145.0%327.0K afterAmended2 lotsDuplicate filing
Apr 17, 2024 (view filing)Apr 413 daysKutzkey TimDirector, 10% OwnerPPurchase+193.5K$15.50+$3.00M+145.0%327.0K afterAmended2 lots
Apr 8, 2024 (view filing)4:23 PM ETApr 44 daysColumn Group III-A, LP and 2 others10% OwnerPPurchase+1.90M–––397.8K afterAmendedDerivative8 lots
Apr 8, 2024 (view filing)Apr 44 daysWilliams Charles OCFO and COOPPurchase+1.47K––New position1.47K after
Apr 8, 2024 (view filing)Apr 44 daysWilliams Charles OCFO and COOPPurchase+14.5K–––5.71K afterDerivative4 lots
Apr 8, 2024 (view filing)Apr 44 daysParker Craig CChief Executive OfficerPPurchase+1.47K––New position1.47K after
Apr 8, 2024 (view filing)Apr 44 daysParker Craig CChief Executive OfficerPPurchase+14.5K–––5.71K afterDerivative4 lots
Apr 8, 2024 (view filing)Apr 44 daysKutzkey TimDirector, 10% OwnerPPurchase+1.90M–––397.8K afterAmendedDerivative8 lots
Dec 15, 2022 (view filing)9:30 AM ETDec 141 dayBlutt Mitchell J MD and 5 others10% OwnerSSale−5.38M––−100.0%0 after4 lots
Dec 15, 2022 (view filing)9:30 AM ETDec 141 dayBlutt Mitchell J MD and 5 others10% OwnerSSale−1.31M–––0 afterDerivative4 lots
Aug 13, 2021 (view filing)7:26 PM ETAug 112 daysBlutt Mitchell J MD and 2 others10% OwnerPPurchase+333.3K–––43.0K afterDerivative3 lots